Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Leukemia & Lymphoma

Font Size

FDA Expands Use for Leukemia Drug

Oncaspar OK'd to Treat Newly Diagnosed Acute Lymphoblastic Leukemia
WebMD Health News
Reviewed by Louise Chang, MD

July 26, 2006 -- Children and adults newly diagnosed with a certain type of leukemialeukemia may now use the drug Oncaspar as part of a multidrug chemotherapy regimen.

The FDA yesterday approved Oncaspar's use in treating newly diagnosed acute lymphoblastic leukemia (ALL) in combination with other chemo drugs.

Previously, Oncaspar was only an approved treatment for acute lymphoblastic leukemia patients who are allergic to Elspar (L-asparaginase), the disease's standard cancercancer drug.

Patients would get three Oncaspar injections instead of 21 Elspar injections over five months of treatment, according to an FDA news release.

"This treatment is a valuable alternative to current therapy," says Steven Galson, MD, MPH, in the FDA news release. Galson directs the FDA's Center for Drug Evaluation and Research.

The FDA approved Oncaspar's expanded use based on a study of 118 pediatric patients. The study showed that Oncaspar "could be safely and effectively substituted for Elspar as part of a multi-drug cancer regimen," states the FDA.

Acute Lymphoblastic Leukemia

Leukemia is a cancer of the white blood cells. Patients with acute leukemia have ineffective white blood cells that cannot help the body fight infections.

Acute lymphoblastic leukemia features an uncontrolled rise in lymphoblasts, which are an immature form of white blood cells called lymphocytes.

In acute lymphoblastic leukemia, the surge in lymphoblasts crowds the bone marrow. That leaves little room in the bone marrow for the body to make other types of blood cells.

Of the 25,000 new cases of leukemia expected in the U.S. this year, acute lymphoblastic leukemia accounts for about 2,500 cases in children and 4,000 in adults, according to the FDA.

Today on WebMD

stem cells
What are they and why do we need them?
Lung cancer xray
See it in pictures, plus read the facts.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Do you know the symptoms?
Vitamin D
New Treatments For Non-Hodgkins Lymphoma
Lifestyle Tips for Depression Slideshow
Pets Improve Your Health